PA
DH icon

PharVision Advisers’s Definitive Healthcare DH Stock Holding History

PharVision Advisers’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-41,769
Closed -$120K – 252
2025
Q4 		$120K Buy
41,769
+12,215
+41% +$33.9K 0.06% 640
2025
Q3 		$120K Buy
+29,554
New +$118K 0.07% 604

Other funds holding DH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PharVision Advisers's DH Position: Q1 2026 in Review

PharVision Advisers sold out of Definitive Healthcare (DH) in Q1 2026, closing a stake of 41,769 shares — an estimated $120K sold.

PharVision Advisers first reported a position in DH in Q3 2025 and held it in 2 quarters. The position peaked at $120K in Q3 2025. 119 funds tracked by Wall St. Rank hold DH as of Q1 2026.

  • PharVision Advisers reported no remaining Definitive Healthcare position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 41,769 Definitive Healthcare shares in Q1 2026, an estimated $120K.
  • PharVision Advisers first reported a position in Definitive Healthcare in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Definitive Healthcare position peaked at $120K in Q3 2025.
  • 119 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.